Dupixent Drives Sanofi Growth Again Amid Pipeline Renewal

First Quarter Earnings Show Increased R&D Spend

Sanofi Has Invested More In R&d In Recent Years • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business